Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban versus warfarin for left ventricular thrombus after myocardial infarction
MOH_2017-11-14_001944Phase 3Recruiting
- Sponsor
- ד"ר רוני אלקלעי
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Left ventricular thrombosis (LVT) comparing Warfarin arm with Apixaban arm (2 arms). Primary endpoint: Not reported. Started Aug 2017; status: recruiting.
02
Drugs
apixabanwarfarin
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on MOH_2017-11-14_001944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-11-14_001944.